- Home
- HUDI vs PYPD Comparison
HUDI vs PYPD Comparison
Compare HUDI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- PYPD
- Stock Information
- Founded
- HUDI 2018
- PYPD 2008
- Country
- HUDI China
- PYPD Israel
- Employees
- HUDI N/A
- PYPD N/A
- Industry
- HUDI Steel/Iron Ore
- PYPD Medical/Dental Instruments
- Sector
- HUDI Industrials
- PYPD Health Care
- Exchange
- HUDI Nasdaq
- PYPD Nasdaq
- Market Cap
- HUDI 23.1M
- PYPD 25.0M
- IPO Year
- HUDI 2021
- PYPD 2020
- Fundamental
- Price
- HUDI $1.40
- PYPD $2.75
- Analyst Decision
- HUDI
- PYPD Strong Buy
- Analyst Count
- HUDI 0
- PYPD 2
- Target Price
- HUDI N/A
- PYPD $10.50
- AVG Volume (30 Days)
- HUDI 8.6K
- PYPD 10.5K
- Earning Date
- HUDI 05-02-2025
- PYPD 05-07-2025
- Dividend Yield
- HUDI N/A
- PYPD N/A
- EPS Growth
- HUDI N/A
- PYPD N/A
- EPS
- HUDI 0.01
- PYPD N/A
- Revenue
- HUDI $74,270,429.00
- PYPD N/A
- Revenue This Year
- HUDI N/A
- PYPD N/A
- Revenue Next Year
- HUDI N/A
- PYPD N/A
- P/E Ratio
- HUDI $150.11
- PYPD N/A
- Revenue Growth
- HUDI N/A
- PYPD N/A
- 52 Week Low
- HUDI $1.40
- PYPD $2.30
- 52 Week High
- HUDI $3.45
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- HUDI 40.93
- PYPD 52.19
- Support Level
- HUDI $1.40
- PYPD $2.65
- Resistance Level
- HUDI $1.54
- PYPD $2.76
- Average True Range (ATR)
- HUDI 0.09
- PYPD 0.11
- MACD
- HUDI -0.01
- PYPD 0.03
- Stochastic Oscillator
- HUDI 0.00
- PYPD 93.75
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.